screen_shot_2013-02-28_at_14

RSA welcomes pan-European consultant

February 28, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing rsa

Life sciences executive search and interim management firm RSA has announced that Dr Theo de Roij has joined the pan-European …

Eliquis image

Eliquis approved by NICE

February 28, 2013
Sales and Marketing BMS, Eliquis, NICE, Pfizer

In a move which will cheer Bristol-Myers Squibb and Pfizer, NICE has recommended oral blood-thinner Eliquis for use on the …

ABPI image

ABPI moves to improve compliance

February 28, 2013
Sales and Marketing ABPI, NHS, alltrials, goldaccre, whiehead

The ABPI has fired its latest salvo in the clinical trial transparency debate by announcing it will appoint a new …

UCB image

UCB warns of data ‘voyeurism’

February 27, 2013
Research and Development, Sales and Marketing EFPIA, UCB, VBP, transparancy

UCB chief executive Roch Doliveux has attacked the idea of making all clinical trial data publicly available, saying it could …

Roche image

Roche increases data access

February 27, 2013
Research and Development, Sales and Marketing ABPI, BMJ, Goldacre, Roche

Roche has launched a new process designed to enable greater access to its clinical trial data for researchers from outside …

annadixon

The King’s Fund’s Anna Dixon joins Department of Health

February 27, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dixon, NHS, king's fund

Director of Policy at The King’s Fund Dr Anna Dixon will be joining the Department of Health in early May …

bad pharma image

Ben Goldacre versus Stephen Whitehead – PharmaTimes Debate

February 27, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BMJ, Bad pharma, Cochrane, Goldacre, Whitehead

In the end, the ‘head to head’ between the UK’s most high profile critic of the pharma industry and ABPI …

Merck image

Merck suffers brain cancer reverse

February 26, 2013
Sales and Marketing Merck, cilengitide

Merck’s oncology programme has suffered a setback as a Phase III trial of its investigational integrin inhibitor cilengitide failed in …

Omontys image

Probe launched as deaths prompt Omontys recall

February 26, 2013
Manufacturing and Production Affymax, Takeda, omontys, recall

Reports of three fatal reactions linked to administration of Takeda and Affymax’ Omontys anaemia treatment have led to a recall …

elan image

Elan sceptical of Royalty

February 26, 2013
Sales and Marketing Elan, FDA, Tysabri, royalty pharma

Elan Corporation has poured tepid water on private equity firm Royalty Pharma’s putative offer this week for the Irish biotech …

Pharma manufacturing news in brief

February 26, 2013
Manufacturing and Production Baxter International, Bone Therapeutic, DSM Pharmaceutical Products and Chemtrix, Sovereign Pharmaceutical

Sovereign Pharma rapped by FDA, facility updates from Bone Therapeutics, Baxter and SHL, plus a continuous processing alliance between DSM …

GSK image

Abbott, GSK cut staff at Irish facilities

February 26, 2013
Manufacturing and Production Abbottt, GSK, Ireland

GlaxoSmithKline and Abbott have both announced job cuts at their facilities in Ireland in a blow to the country’s pharmaceutical …

Continuous processing production line set up in Finland

February 25, 2013
Manufacturing and Production Finland, PROMIS

A specialist centre in Finland providing expertise in the continuous processing of pharmaceuticals, first envisaged in 2008, opened its doors …

screen_shot_2013-02-25_at_16

Pharmalink Consulting appoints five consultants

February 25, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmalink Consulting

Regulatory affairs firm Pharmalink Consulting has announced the appointment and promotion of five consultants at their offices in the UK, …

Abbott image

Abbott seeks leukemia test

February 25, 2013
Sales and Marketing AbbVie, Abbott, Janssen

Abbott is to team up with Janssen Biotech and biopharma firm Pharmacyclics to seek a diagnostic test for leukemia patients. …

herceptinbank

FDA approves Kadcyla

February 25, 2013
Herceptin, Roche, T-DM1

Roche’s new ‘smart bomb’ breast cancer drug Kadcyla has been approved by the FDA, giving it hope of replacing revenue …

$33m prizes for research

February 22, 2013
Research and Development Breakthrough Prize in Life Sciences, Cancer, Facebook, google

Life science research has a new multi-million dollar prize from the founders of Facebook and Google.The not-for-profit Breakthrough Prize in …

Ariad expands in Europe

February 22, 2013
Sales and Marketing Ariad, leukaemia, leukemia

The new European boss of Ariad Pharmaceuticals has sketched out the US firm’s plans for its next-generation leukaemia drug, which …

Roche image

Roche censured for drunken conference antics

February 21, 2013
Medical Communications, Sales and Marketing ABPI, PMCPA, Roche

The conduct of senior Roche employees has come under the spotlight following a complaint about drunkenness and poor behaviour at …

Watson: the supercomputer revolution begins here

February 21, 2013
Medical Communications Watson, ibm

Watson, a supercomputer developed by IBM is to make its debut helping oncologists diagnose and choose the best treatment for …

The Gateway to Local Adoption Series

Latest content